Lurie Center for Autism Massachusetts General Hospital Harvard Medical School
Psychiatry
Dr. Christopher J. McDougle, MD
|
|
Give Review
Dr. Christopher J. McDougle works in the field of Psychiatry. He graduated from Indiana University School of Medicine. Indiana University School of Medicine has a rank of 45 in research and a 47 in primary care He has 3 awards "America's Top Doctors", "Boston Magazine" and "Indianapolis Monthly". Christopher McDougle is a published doctor as well. He has 102 publications published. The latest was: Brief Report: Autism Spectrum Disorder and Substance Use Disorder: A Review and Case Study. Doctor Christopher J. McDougle, MD is registered with Medicare and accepts Medicare payments.
Publications
- A Pilot Study of Autism-Specific Care Plans During Hospital Admission.
- Psychopharmacologic treatment of children prenatally exposed to drugs of abuse.
- A systematic review of molecular imaging (PET and SPECT) in Autism spectrum disorder: Current state and future research opportunities.
- Toward an immune-mediated subtype of Autism spectrum disorder.
- Multidisciplinary Assessment and Treatment of Self-Injurious Behavior in Autism Spectrum Disorder and Intellectual Disability: Integration of Psychological and Biologi...
- Brief Report: Bone Fractures in Children and Adults with Autism Spectrum Disorders.
- Impact of acamprosate on plasma amyloid-β precursor protein in youth: A pilot analysis in fragile X syndrome-associated and idiopathic Autism spectrum disorder suggest...
- Body Mass Index Change in Autism Spectrum Disorders: Comparison of Treatment with Risperidone and Aripiprazole.
- N-Acetylcysteine for Neuropsychiatric Symptoms in a Woman With Williams Syndrome.
- Examination of Aggression and Self-injury in Children with Autism Spectrum Disorders and Serious Behavioral Problems.
- Brief Report: Pilot Single-Blind Placebo Lead-In Study of Acamprosate in Youth with Autistic Disorder.
- Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with Autism spectrum disorders.
- Changes in the diagnostic criteria for Autism in DSM-5: controversies and concerns.
- Sounding a wake-up call: improving the lives of adults with Autism.
- Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental Disorders.
- Brief Report: Social Disability in Autism Spectrum Disorder: Results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network Trials.
- Impact of acamprosate on behavior and brain-derived neurotrophic factor: an open-label study in youth with fragile X syndrome.
- Exploring the Manifestations of Anxiety in Children with Autism Spectrum Disorders.
- Neuroinflammation and Autism: toward mechanisms and treatments.
- Pharmacologic treatments for the behavioral symptoms associated with Autism spectrum disorders across the lifespan.
- Pharmacotherapy to control behavioral symptoms in children with Autism.
- The Effects of Aripiprazole on Electrocardiography in Children with Pervasive Developmental Disorders.
- An Open-Label Naturalistic Pilot Study of Acamprosate in Youth with Autistic Disorder.
- Buspirone for Bruxism in a Child with Pervasive Developmental Disorder-Not Otherwise Specified.
- Risperidone-Related Improvement of Irritability in Children with Autism Is not Associated with Changes in Serum of Epidermal Growth Factor and Interleukin-13.
- A novel approach of homozygous haplotype sharing identifies candidate genes in Autism spectrum disorder.
- Paliperidone palmitate in a child with autistic disorder.
- Memantine for comorbid obsessive-compulsive disorder and asperger disorder suggests a link in glutamatergic dysregulation.
- Riluzole in Autistic Disorder.
- Predictors and Moderators of Parent Training Efficacy in a Sample of Children with Autism Spectrum Disorders and Serious Behavioral Problems.
- Case Report: 16-Year-Old Male with Autistic Disorder with Preoccupation with Female Feet.
- Guanfacine extended release in two patients with pervasive developmental Disorders.
- A prospective open-label study of aripiprazole in fragile X syndrome.
- Brief report: acamprosate in fragile X syndrome.
- Pharmacologic treatment of behavioral symptoms associated with Autism and other pervasive developmental disorders.
- Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years.
- Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period.
- Aripiprazole in Autism spectrum disorders and fragile X syndrome.
- Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability.
- Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental Disorders and hyperac...
- Paliperidone for irritability in autistic disorder.
- Co-morbid intellectual disability and borderline personality disorder: a case series.
- Open-Label Memantine in Fragile X Syndrome.
- Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.
- Trial design challenges when combining medication and parent training in children with pervasive developmental Disorders.
- A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder.
- Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental Disorders and hyperactivity.
- Gastrointestinal symptoms in a sample of children with pervasive developmental Disorders.
- Beware of over-interpreting negative trials.
- Treating Autism spectrum disorders. Preface.
- Pharmacotherapy of irritability in pervasive developmental Disorders.
- Developing drugs for core social and communication impairment in Autism.
- Cognitive effects of risperidone in children with Autism and irritable behavior.
- It is time to take a stand for medical research and against terrorism targeting medical scientists.
- Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core Autism symptoms and cognitive functioning.
- Antipsychotics in the treatment of Autism.
- Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental Disorders.
- Pharmacologic treatment of Autism and related disorders.
- Effects of short- and long-term risperidone treatment on prolactin levels in children with Autism.
- Developmental disabilities modification of the Children's Global Assessment Scale.
- Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental Disorders: an analysis of secondary measures.
- Guanfacine and guanfacine extended release: treatment for ADHD and related Disorders.
- A prospective open trial of guanfacine in children with pervasive developmental Disorders.
- Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental Disorders.
- Ramelteon for insomnia in two youths with autistic disorder.
- Validity of the Autism diagnostic interview-revised.
- Risperidone and adaptive behavior in children with Autism.
- The use of selective serotonin reuptake inhibitors in Autism and related disorders.
- Gastrointestinal factors in autistic disorder: a critical review.
- Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone.
- Acute and long-term safety and tolerability of risperidone in children with Autism.
- Obsessive-compulsive disorder (OCD).
- Acute onset of obsessive-compulsive disorder in an adolescent with acute lymphoblastic leukemia.
- Pharmacological management of agitation and aggression in an adolescent with Autism.
- Risperidone for the core symptom domains of Autism: results from the study by the Autism network of the research units on pediatric psychopharmacology.
- Research knowledge among parents of children participating in a randomized clinical trial.
- Neurochemistry in the pathophysiology of Autism.
- A pilot study of D-cycloserine in subjects with autistic disorder.
- A retrospective analysis of quetiapine in the treatment of pervasive developmental Disorders.
- Increased cerebrospinal fluid corticotropin-releasing factor concentrations during tryptophan depletion in healthy adults.
- Brief report: autistic disorder in three children with cytomegalovirus infection.
- Methylphenidate an effective treatment for ADHD?
- Weight and leptin changes among risperidone-treated youths with Autism: 6-month prospective data.
- Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects.
- High nitric oxide production in autistic disorder: a possible role for interferon-gamma.
- A naturalistic retrospective analysis of psychostimulants in pervasive developmental Disorders.
- Ziprasidone treatment of two adolescents with psychosis.
- Guanfacine treatment of hyperactivity and inattention in pervasive developmental Disorders: a retrospective analysis of 80 cases.
- Aripiprazole for maladaptive behavior in pervasive developmental Disorders.
- Intramuscular ziprasidone for acute agitation in adolescents.
- Increased prevalence of familial autoimmunity in probands with pervasive developmental Disorders.
- High blood monocyte counts and neopterin levels in children with autistic disorder.
- Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric Disorders.
- Treatment of aggression in children and adolescents with Autism and conduct disorder.
- Genetics of childhood disorders: XLIV. Autism, part 3: psychopharmacology of Autism.
- Case series: use of ziprasidone for maladaptive symptoms in youths with Autism.
- Priapism associated with trazodone in an adolescent with Autism.
- The amygdala and related structures in the pathophysiology of Autism.
- Acute tryptophan depletion in schizophrenic patients treated with clozapine.
- Brief Report: Autism Spectrum Disorder and Substance Use Disorder: A Review and Case Study.
- Sensitivity of the modified Children's Yale-Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials.
Schools
Indiana University School of Medicine
Ct Mntl Health Center
Yale New Haven Hospital
Conditions Treated
- Autism
- Dysthymia and Cyclothymia (Mood Disorders)
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- Indianapolis Monthly
Education
-
Yale-New Haven Hospital -
Indiana University School of Medicine
Hospital
-
Newton-Wellesley Hospital -
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1871547497 | |
| NPPES Provider LastName | MCDOUGLE | |
| NPPES Provider FirstName | CHRISTOPHER | |
| NPPES Provider ZIPCode | 462025128 | |
| NPPES Provider State | IN | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 201.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871547497 |
| Last Name Of The Provider | MCDOUGLE |
| First Name Of The Provider | CHRISTOPHER |
| View All |
Similar Doctors
|
|
Dr. Sharon R. Weinstein, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard M. Brostoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John T. Maltsberger III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Geoffrey E. Linburn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine Lanteri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William N. Browning, MD |